Your browser doesn't support javascript.
loading
Performance of rapid antigen tests in identifying Omicron BA.4 and BA.5 infections in South Africa.
Samsunder, Natasha; Lustig, Gila; de Vos, Margaretha; Ngcapu, Sinaye; Giandhari, Jennifer; Tshiabuila, Derek; San, Emmanuel James; Lewis, Lara; Kharsany, Ayesha Bm; Cawood, Cherie; de Oliveira, Tulio; Abdool Karim, Quarraisha; Abdool Karim, Salim; Escadafal, Camille; Naidoo, Kogieleum; Sivro, Aida.
Afiliación
  • Samsunder N; Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa.
  • Lustig G; Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa.
  • de Vos M; FIND, Geneva, Switzerland.
  • Ngcapu S; Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa; Department of Medical Microbiology, University of KwaZulu-Natal, Durban, South Africa.
  • Giandhari J; KwaZulu-Natal Research Innovation and Sequencing Platform, Durban, South Africa.
  • Tshiabuila D; KwaZulu-Natal Research Innovation and Sequencing Platform, Durban, South Africa.
  • San EJ; KwaZulu-Natal Research Innovation and Sequencing Platform, Durban, South Africa.
  • Lewis L; Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa.
  • Kharsany AB; Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa; Department of Medical Microbiology, University of KwaZulu-Natal, Durban, South Africa.
  • Cawood C; Epicentre AIDS Risk Management (Pty) Limited, Durban, South Africa.
  • de Oliveira T; Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa; KwaZulu-Natal Research Innovation and Sequencing Platform, Durban, South Africa; Centre for Epidemic Response and Innovation, School of Data Science and Computational Thinking, Stellenbosch University, Stellen
  • Abdool Karim Q; Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa; Department of Epidemiology, Columbia University, New York City, United States of America.
  • Abdool Karim S; Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa; Department of Epidemiology, Columbia University, New York City, United States of America.
  • Escadafal C; FIND, Geneva, Switzerland.
  • Naidoo K; Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa; MRC-CAPRISA HIV-TB Pathogenesis and Treatment Research Unit, Doris Duke Medical Research Institute, University of KwaZulu-Natal, South Africa.
  • Sivro A; Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa; Department of Medical Microbiology, University of KwaZulu-Natal, Durban, South Africa; JC Wilt Infectious Disease Research Centre, National Microbiology laboratory, Public Health Agency of Canada, Winnipeg, MB
J Clin Virol ; 165: 105498, 2023 08.
Article en En | MEDLINE | ID: mdl-37329842
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans País/Región como asunto: Africa Idioma: En Revista: J Clin Virol Asunto de la revista: VIROLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Sudáfrica Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans País/Región como asunto: Africa Idioma: En Revista: J Clin Virol Asunto de la revista: VIROLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Sudáfrica Pais de publicación: Países Bajos